What is stopping us from using flumazenil?

Addiction

Volumn 107, Issue 7, 2012, Pages 1359-1359

  Lugoboni, Fabio ^a   Leone, Roberto ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; HYPNOTIC SEDATIVE AGENT;

ADDICTION; FEMALE; HUMAN; MALE; NOTE; PATHOPHYSIOLOGY; PRIMARY HEALTH CARE; STATISTICS; WITHDRAWAL SYNDROME;

BENZODIAZEPINES; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; PRIMARY HEALTH CARE; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 84861951964     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2012.03851.x     Document Type: Letter

References (5)

1. Lader M. Benzodiazepines revisited-will we ever learn? Addiction 2011; 106: 2086-109.
2. Lugoboni F., Faccini M., Quaglio G. L., Albiero A., Pajusco B. Intravenous flumazenil infusion to treat benzodiazepine dependence should be performed in the inpatient clinical setting for high risk of seizure. J Psychopharmacol 2011; 26: 848-9.
3. Quaglio G. L., Lugoboni F., Fornasiero A., Lechi A., Gerra G., Mezzelani P. Dependance on zolpidem: two case reports of detoxification with flumazenil infusion. Int Clin Psychopharmacol 2005; 20: 285-7.
4. Hood S., O'Neil G., Hulse G. The role of flumazenil in the treatment of benzodiazepine dependence: physiological and psychological profiles. J Psychopharmacol 2009; 23: 401-9.
5. Albiero A., Brigo F., Faccini M., Casari R., Quaglio G., Storti M. etal. Focal nonconvulsive seizures during detoxification for benzodiazepine abuse. Epilepsy Behav 2011; 23: 168-70.